Cathy Wood''s ARK Genomic Revolution ETF Increases Stake In Atai Life Sciences To Record Highs
After a pause in the purchase of atai Life Sciences N.V. (NASDAQ:ATAI ) shares, Cathy Wood’s ARK Genomic Revolution ETF is back on the bid. The actively managed Fund that invests in early-stage emerging technology companies has increased its stake in atai to record amounts, presumably seeing value in the psychedelic biotech leader that’s been hit during the ongoing selloff in risk assets. According to updated ARK Genomic Revolution ETF holdings spreadsheet, the fund now owns 1,827,047 million shares—above the previous high of 1.689 million shares held in March, according to cathiesark.com. The aggregate jump in share ownership is the biggest increase since mid-March, when the ETF increased its stake by over 200,000 shares during the period March 11-14 period. Below, we … Full story available on Benzinga.com
Cathy Wood''s ARK Genomic Revolution ETF Increases Stake In Atai Life Sciences To Record Highs
After a pause in the purchase of atai Life Sciences N.V. (NASDAQ:ATAI ) shares, Cathy Wood’s ARK Genomic Revolution ETF is back on the bid. The actively managed Fund that invests in early-stage emerging technology companies has increased its stake in atai to record amounts, presumably seeing value in the psychedelic biotech leader that’s been hit during the ongoing selloff in risk assets. According to updated ARK Genomic Revolution ETF holdings spreadsheet, the fund now owns 1,827,047 million shares—above the previous high of 1.689 million shares held in March, according to cathiesark.com. The aggregate jump in share ownership is the biggest increase since mid-March, when the ETF increased its stake by over 200,000 shares during the period March 11-14 period. Below, we … Full story available on Benzinga.com